Orexo AB (ORXOF) Enhances Commercial Focus And Operating Efficiencies
8/20/2014 11:45:05 AM
UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: Orexo AB (publ) announces today that the company is taking further steps to enhance commercial focus, agility and operating efficiency. The sales development of Zubsolv® continues to evolve positively with the tablet sales increasing 64% in volume the last four weeks compared to the last month of the second quarter. The market share has improved from 2.3% in June to 3.9% in the first week of August. This positive sales development is primarily driven by improvements in Zubsolv’s market access position and the exclusive contract with UnitedHealth Group in particular.
Help employers find you! Check out all the jobs and post your resume.
comments powered by